Research press release



Virology: Cows herd immunity against HIV


広域中和抗体は、一部のHIV感染者の体内で生成され、HIV免疫療法は、そうした抗体の作製を誘導できるワクチンの開発を目標としている。この効果をヒトとさまざまな動物モデルの体内で実現することは難題となっており、その理由として、一部の動物が、広域中和抗体に成熟するために必要な前駆体を十分に保有していないことが1つの可能性として挙がっている。これに対してウシの体内で生成される抗体は、他の動物の場合より広域中和抗体に成熟する能力が高いと考えられている。そこでDennis Burtonたちの研究グループは、HIVエンベロープを模倣するように設計されたBG505 SOSIPタンパク質を使って4頭のウシを免疫した。



Broadly neutralizing antibodies that can inhibit multiple strains of HIV can be generated rapidly in cows after repeated immunization with a protein that mimics the HIV envelope, reports a study published online in Nature this week. The findings may inform HIV vaccine design, although it remains uncertain whether the same approach could elicit a similar response in humans.

Broadly neutralizing antibodies are generated in a subset of people infected with HIV, and a goal of HIV immunotherapy is to produce a vaccine that could induce the generation of these antibodies. This effect has been difficult to achieve in in humans and a variety of animal models, possibly because some animals do not have sufficient precursors required to mature into broadly neutralizing antibodies. Cows, however, produce antibodies that may have greater potential to become broadly neutralizing. Thus, Dennis Burton and colleagues immunized four cows with a protein called BG505 SOSIP, which has been designed to mimic the HIV envelope - the outer membrane of the virus.

They observe rapid generation of broadly neutralizing antibodies following immunization; one cow produced antibodies capable of neutralizing 20% of the 117 HIV subtypes tested after 42 days, increasing to 96% breadth by 381 days. The length of time required to produce similar antibodies in humans through natural infection is over five years. Previous experiments on llamas immunized with envelope proteins produced broadly neutralizing antibodies with low potency and limited breadth only after more than four months.

These findings indicate that some of the challenges faced in attempts to develop a vaccine for HIV may be due to the limited repertoire of human antibodies. However, the rapid response observed in cows suggests that they may be an ideal model for producing antibodies against other disease-causing organisms to aid the design of a range of vaccines, the authors conclude.

doi: 10.1038/nature23301|英語の原文

「Nature 関連誌注目のハイライト」は、ネイチャー広報部門が報道関係者向けに作成したリリースを翻訳したものです。より正確かつ詳細な情報が必要な場合には、必ず原著論文をご覧ください。


メールマガジンリストの「Nature 関連誌今週のハイライト」にチェックをいれていただきますと、毎週最新のNature 関連誌のハイライトを皆様にお届けいたします。